The following tables summarize the information relating to the Company’s majority-owned subsidiaries, CC Pharma Nordic ApS (75%), Aphria Diamond (51%), ColCanna S.A.S. (90%), and SH Acquisition (68%) before intercompany eliminations.

Summarized balance sheet information of the entities in which there is a non-controlling interest as at May 31, 2022:

	CC Pharma			Aphria			SH		ColCanna
	Nordic ApS			Diamond			Acquisition		S.A.S.			Total
Current assets	$	485		$	20,546		$	—	$	193		$	21,224
Non-current assets		158			152,786			111,200		141,929			406,073
Current liabilities		(642	)		(63,196	)		—		(53	)		(63,891	)
Non-current liabilities		(410	)		(29,653	)		—		(6,537	)		(36,600	)
Net assets		(409	)		80,483			111,200		135,532			326,806

Summarized balance sheet information of the entities in which there is a non-controlling interest as at May 31, 2021:

	CC Pharma			Aphria			SH		ColCanna
	Nordic ApS			Diamond			Acquisition		S.A.S.			Total
Current assets	$	919		$	19,531		$	—	$	315		$	20,765
Non-current assets		103			153,696			—		146,587			300,386
Current liabilities		(956	)		(28,511	)		—		(62	)		(29,529	)
Non-current liabilities		(406	)		(69,332	)		—		(6,606	)		(76,344	)
Net assets		(340	)		75,384			—		140,234			215,278

Summarized income statement information of the entities in which there is a non-controlling interest for the year ended May 31, 2022:

	CC Pharma			Aphria			SH			ColCanna
	Nordic ApS			Diamond			Acquisition			S.A.S.			Total
Revenue	$	354		$	148,323		$	—		$	—		$	148,677
Total expenses (recovery)		470			77,057			(11,180	)		35			66,382
Net (loss) income		(116	)		71,266			11,180			(35	)		82,295
Other comprehensive (loss) income		47			(2,353	)		(70,778	)		(4,737	)	$	(77,821	)
Net comprehensive income		(69	)		68,913			(59,598	)		(4,772	)		4,474

Summarized income statement information of the entities in which there is a non-controlling interest for the year ended May 31, 2021:

	CC Pharma			Aphria		ColCanna
	Nordic ApS			Diamond		S.A.S.			Total
Revenue	$	827		$	131,381	$	—		$	132,208
Total expenses (recovery)		958			67,030		923			68,911
Net (loss) income		(131	)		64,351		(923	)		63,297
Other comprehensive (loss) income		—			—		—			—
Net comprehensive loss		(131	)		64,351		(923	)		63,297

Summarized income statement information of the entities in which there is a non-controlling interest for the year ended May 31, 2020:

	Aphria Diamond			Marigold			ColCanna S.A.S.			Total
Revenue	$	24,142		$	40		$	—		$	24,182
Total expenses (recovery)		25,141			(4,995	)		(19,447	)		699
Net (loss) income		(999	)		5,035			19,447			23,483
Other comprehensive (loss) income		—			—			—			—
Net comprehensive loss		(999	)		5,035			19,447			23,483